Sunday, January 23rd, 2022

Tag: nuclear therapy

The blood-brain barrier (BBB) penetrating drugs market

Advances in biotechnology have enabled the development of versatile in vitro (static and dynamic), in vivo (micro-dialysis), and in situ (brain perfusion) blood–brain barrier models, allowing more effective and safe delivery of drugs across...

The nuclear medicine and radiopharmaceutical manufacturing market

The recent surge in the demand of radiopharmaceuticals for diagnostic and therapeutic applications, coupled with the introduction of theranostics, has opened up opportunities for companies having capabilities to manufacture nuclear medicine and radiopharmaceuticals Roots...